Recommendations on treatment for IPF

Respiratory Research

Volumn 14, Issue SUPPL. 1, 2013, Pages

  Behr, Jürgen ^a   Richeldi, Luca ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Guidelines; Idiopathic Pulmonary Fibrosis (IPF); Recommendations; Treatment

Indexed keywords

ACETYLCYSTEINE; AZATHIOPRINE; PIRFENIDONE; PREDNISONE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; RESPIRATORY TRACT AGENT;

ARTICLE; CLINICAL PRACTICE; DRUG APPROVAL; DRUG SAFETY; FIBROSING ALVEOLITIS; HEALTH CARE ORGANIZATION; HUMAN; PATIENT CARE; PRACTICE GUIDELINE; EVIDENCE BASED MEDICINE; IDIOPATHIC PULMONARY FIBROSIS; INTERNATIONAL COOPERATION; PULMONOLOGY; STANDARDS; STANDARD;

ADRENAL CORTEX HORMONES; ANTIBODIES, MONOCLONAL; EVIDENCE-BASED MEDICINE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; IMMUNOSUPPRESSIVE AGENTS; INTERNATIONALITY; PRACTICE GUIDELINES AS TOPIC; PULMONARY MEDICINE; RESPIRATORY SYSTEM AGENTS;

EID: 84876302562     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-14-S1-S6     Document Type: Article

References (15)

1. ATS/ERS. Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment. International Consensus Statement. Am J Crit Care Respir Med 2000, 161:646-664.
2. Guyatt G, Gutterman D, Baumann NH, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians Task Force. Chest 2006, 129:174-181. 10.1378/chest.129.1.174, 16424429.
3. Schunemann HJ, Jaeschke R, Cook DJ, et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respr Crit Care Med 2006, 174:605-614.
4. ATS/ERS/JRS/ALAT An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-Based Guidelines For Diagnosis and Management. Am J Respir Crit Care Med 2011, 183:788-824. 10.1164/rccm.2009-040GL, 21471066, ATS/ERS/JRS/ALAT.
5. Gay SE, Kazerooni EA, Toews GB, et al. Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am J Respir Crit Care Med 1998, 157:1063-1072. 10.1164/ajrccm.157.4.9703022, 9563720.
6. Raghu G, Brown KK, Bradford WG, et al. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 2004, 350:125-133. 10.1056/NEJMoa030511, 14711911.
7. King TE, Albera C, Bradford WX, et al. Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial. Lancet 2009, 374:222-228. 10.1016/S0140-6736(09)60551-1, 19570573.
8. Demedts M, Behr J, Buhl R, et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2005, 353:2229-2242. 10.1056/NEJMoa042976, 16306520.
9. Raghu G, Anstrom KJ, et al. Idiopathic Pulmonary Fibrosis Clinical Research Network Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 2012, 366:1968-1977. 3422642, 22607134, Idiopathic Pulmonary Fibrosis Clinical Research Network.
10. Kubo H, Nakayama K, Yanai M, et al. Anticoagulant therapy for idiopathic pulmonary fibrosis. Chest 2005, 128:1475-1482. 10.1378/chest.128.3.1475, 16162746.
11. Noth I, Anstrom KJ, Calvert SB, et al. A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2012, 186:88-95. 10.1164/rccm.201202-0314OC, 22561965.
12. Azuma A, Nukiwa T, Tsuboi E, et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respi Crit Care Med 2005, 171:1040-1047.
13. Taniguchi H, Ebina M, Kondoh Y, et al. Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J 2010, 35:821-829. 10.1183/09031936.00005209, 19996196.
14. Noble PW, Albera C, Bradford WZ, et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet 2011, 377:1760-1769. 10.1016/S0140-6736(11)60405-4, 21571362.
15. Spagnolo P, Del Giovane C, Luppi F, et al. Non-steroid agents for idiopathic pulmonary fibrosis (Review). Cochrane Database Syst Rev 2010, 9:CD003134.